Ventas, Inc. (NYSE:VTR – Get Free Report) Director Michael Embler purchased 2,500 shares of the stock in a transaction dated Wednesday, June 3rd. The stock was purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the acquisition, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. This represents a 14.97% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website.
Ventas Stock Up 0.1%
NYSE:VTR opened at $82.13 on Monday. Ventas, Inc. has a fifty-two week low of $61.76 and a fifty-two week high of $91.06. The stock has a market capitalization of $39.93 billion, a P/E ratio of 149.33, a P/E/G ratio of 1.81 and a beta of 0.71. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. The company’s 50-day simple moving average is $85.05 and its 200-day simple moving average is $82.39.
Ventas (NYSE:VTR – Get Free Report) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the business posted $0.84 earnings per share. The firm’s quarterly revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities analysts anticipate that Ventas, Inc. will post 3.88 earnings per share for the current fiscal year.
Ventas Announces Dividend
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the stock. Scotiabank upped their price objective on shares of Ventas from $93.00 to $95.00 and gave the company a “sector perform” rating in a report on Thursday, May 21st. Argus set a $88.00 price objective on shares of Ventas in a report on Tuesday, February 10th. JPMorgan Chase & Co. upped their price objective on shares of Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Monday, May 11th. BMO Capital Markets restated an “outperform” rating and set a $100.00 price objective on shares of Ventas in a report on Monday, May 4th. Finally, Citigroup upped their price objective on shares of Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a report on Friday, May 1st. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $95.19.
Read Our Latest Report on Ventas
Institutional Trading of Ventas
Several large investors have recently made changes to their positions in the business. BI Asset Management Fondsmaeglerselskab A S grew its position in Ventas by 97.7% during the 3rd quarter. BI Asset Management Fondsmaeglerselskab A S now owns 36,713 shares of the real estate investment trust’s stock worth $2,570,000 after purchasing an additional 18,146 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Ventas by 2.5% in the 3rd quarter. Vanguard Group Inc. now owns 73,598,827 shares of the real estate investment trust’s stock valued at $5,151,182,000 after buying an additional 1,802,515 shares during the period. Schroder Investment Management Group boosted its stake in shares of Ventas by 3.6% in the third quarter. Schroder Investment Management Group now owns 2,487,572 shares of the real estate investment trust’s stock worth $170,946,000 after buying an additional 85,340 shares during the last quarter. Krilogy Financial LLC acquired a new stake in Ventas during the third quarter worth about $919,000. Finally, Aberdeen Group plc grew its holdings in Ventas by 8.3% during the third quarter. Aberdeen Group plc now owns 1,580,923 shares of the real estate investment trust’s stock worth $109,985,000 after acquiring an additional 120,825 shares during the period. 94.18% of the stock is owned by hedge funds and other institutional investors.
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
See Also
- Five stocks we like better than Ventas
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
